Literature DB >> 15348367

Does a pro-angiogenic state exist in the bone-implant interface of aseptically loosened joint prosthesis?

G M Jell1, N Al-Saffar.   

Abstract

Neovascularization is indispensable to both bone remodeling and the development of chronic inflammation. A pro-angiogenic state in the periprosthetic tissue may augment the inflammatory response to wear debris. To investigate if a pro-angiogenic state exists in the bone-implant interface of aseptically loosened joint prosthesis, the expression of vascular endothelial growth factor (VEGF) and its receptor Flk-1/KDR were studied by immunohistochemistry. The VEGF-Flk/KDR pathway has been implicated as a key signaling requirement for pathological angiogenesis. The level of vascularization in periprosthetic tissue was semi-quantitatively compared to osteoarthritic (OA) and rheumatoid arthritic (RA) synovium. The level of vascularization in areas of periprosthetic tissue with heavy or low/moderate wear debris were also compared semi-quantitatively by image analysis. High levels of VEGF expression (16/16 cases) particularly in the implant synovial-like lining layer together with Flk-1/KDR expression by endothelial cells (13/16), suggests that neovascularization is occurring. Morphometric comparison of periprosthetic tissue with RA and OA synovium revealed no significant difference in microvessel density, but did reveal significantly increased microvessel area in RA synovium (P > 0.05). Areas of high wear debris infiltrate also contained a significantly smaller microvessel area (P > 0.01). Suggesting that wear debris may cause behavioral modification of microvessels. Modifying angiogenesis in the periprosthetic tissue could be a potential therapeutic target in reducing inflammation. Copyright 2001 Kluwer Academic Publishers

Entities:  

Year:  2001        PMID: 15348367     DOI: 10.1023/a:1012858426382

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  21 in total

Review 1.  Clinical applications of angiogenic growth factors and their inhibitors.

Authors:  N Ferrara; K Alitalo
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.

Authors:  A Giatromanolaki; E Sivridis; N Athanassou; E Zois; P E Thorpe; R A Brekken; K C Gatter; A L Harris; I M Koukourakis; M I Koukourakis
Journal:  J Pathol       Date:  2001-05       Impact factor: 7.996

3.  Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants.

Authors:  N al-Saffar; J T Mah; Y Kadoya; P A Revell
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

4.  Periprosthetic microvasculature in loosening of total hip replacement.

Authors:  S Santavirta; A Ceponis; S A Solovieva; H Hurri; J Jin; M Takagi; A Suda; Y T Konttinen
Journal:  Arch Orthop Trauma Surg       Date:  1996       Impact factor: 3.067

5.  Induction of stress proteins in human endothelial cells by heavy metal ions and heat shock.

Authors:  M Wagner; I Hermanns; F Bittinger; C J Kirkpatrick
Journal:  Am J Physiol       Date:  1999-11

6.  Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice.

Authors:  H Sone; Y Kawakami; M Sakauchi; Y Nakamura; A Takahashi; H Shimano; Y Okuda; T Segawa; H Suzuki; N Yamada
Journal:  Biochem Biophys Res Commun       Date:  2001-02-23       Impact factor: 3.575

7.  Tumor necrosis factor-alpha (TNF-alpha) in loosening of total hip replacement (THR).

Authors:  J W Xu; Y T Konttinen; J Lassus; S Natah; A Ceponis; S Solovieva; P Aspenberg; S Santavirta
Journal:  Clin Exp Rheumatol       Date:  1996 Nov-Dec       Impact factor: 4.473

Review 8.  New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders.

Authors:  S C Ballara; J M Miotla; E M Paleolog
Journal:  Int J Exp Pathol       Date:  1999-10       Impact factor: 1.925

9.  Relationships between endothelial cells, pericytes, and osteoblasts during bone formation in the sheep femur following implantation of tricalciumphosphate-ceramic.

Authors:  B Decker; H Bartels; S Decker
Journal:  Anat Rec       Date:  1995-07

Review 10.  Role of microvascular endothelial cells in inflammation.

Authors:  R A Swerlick; T J Lawley
Journal:  J Invest Dermatol       Date:  1993-01       Impact factor: 8.551

View more
  3 in total

Review 1.  Gene activation by bioactive glasses.

Authors:  G Jell; M M Stevens
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

2.  Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis.

Authors:  David C Markel; Renwen Zhang; Tong Shi; Monica Hawkins; Weiping Ren
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

3.  Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model.

Authors:  Weiping Ren; Renwen Zhang; Bin Wu; Paul H Wooley; Monica Hawkins; David C Markel
Journal:  J Inflamm Res       Date:  2011-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.